Posted by Martha on 10/15/2009, 2:12 pm Link: http://www.medscape.com/viewarticle/710421
68.12.160.104
NEW YORK (Reuters Health) Oct 13 - The benefit of adding inhaled corticosteroids to long-acting beta-2 agonists for treating chronic obstructive pulmonary disease (COPD) is limited, and furthermore, it's accompanied by substantial risks of pneumonia and other infections.
The rest of the article can be read at the link.
Responses: